Treatment to Promote Self-regulation in Children With Autism Spectrum Disorder
Recruiting now Phase 2 NCT05235919
Run by Holland Bloorview Kids Rehabilitation Hospital · for 9 to 18 · All sexes
What this study is about
This study will evaluate the feasibility of repetitive Transcranial Magnetic Stimulation (rTMS) in Autism Spectrum Disorder (ASD) with self-regulation impairment. Baseline and follow-up participant visits will include behavioral assessments of self-regulation and magnetic resonance imaging (MRI) to determine neurophysiological outcomes before and after rTMS treatment.
Who can join (things the study team will check)
✅ You may be able to join if…
- Children with a diagnosis of autism spectrum disorder and self-regulation impairment or challenges
- Able to participate in rTMS
🚫 You may not be able to join if…
- Children with autism spectrum disorder but no co-morbid self-regulation disorders.
- Children with contraindications to TMS (history of seizures, family history of seizures, metal implants)
- Co-existing neurological conditions (epilepsy, stroke, etc.)
Where this trial is running
- Bloorivew Research Institute, Toronto, Ontario, Canada
Who to contact
Deryk Beal, PhD · 416-425-6220 · dbeal@hollandbloorview.ca
It's completely normal to call and ask questions before deciding anything. Mention the study ID: NCT05235919.
Verify everything on the official ClinicalTrials.gov record. Page updated July 2026.
Beacon is an information tool, not medical advice. Whether a trial is right for you is a decision for you, your doctor, and the study team. Trial details come from the official registry, ClinicalTrials.gov, and may change — always confirm with the study team. Beacon collects no data about you: this page has no cookies, no accounts, and no tracking.